(WO/2001/030321) ORAL DOSAGE FORM COMPRISING A SALT OF MORPHINE OR A MORPHINE DERIVATIVE
- Biblio. Data
- Description
- Claims
- National Phase
- Notices
- Documents
| Latest bibliographic data on file with the International Bureau
| |||||||||||||||||||
| |||||||||||||||||||
| IPC: | A61K 31/485 (2006.01), A61K 9/00 (2006.01), A61K 9/20 (2006.01) | ||||||||||||||||||
| Applicants: | ALKALOID AD [MK/MK]; Bul. Aleksandar Makedonski, 12
9100 Skopje (MK) (All Except US). UGARKOVIC, Sonja, Joran [MK/MK]; (MK) (US Only). | ||||||||||||||||||
| Inventor: | UGARKOVIC, Sonja, Joran; (MK). | ||||||||||||||||||
| Agent: | BROWNE, Robin, Forsythe; Urquhart-Dykes & Lord Tower House Merrion Way Leeds LS2 8PA (GB). | ||||||||||||||||||
| Priority Data: |
| ||||||||||||||||||
| Title: | ORAL DOSAGE FORM COMPRISING A SALT OF MORPHINE OR A MORPHINE DERIVATIVE | ||||||||||||||||||
| Abstract: | A pharmaceutical sublingual solid dosage form comprising a morphine salt together with excipients including a saccharide, a binder and a disintegrant. A method of manufacturing the dosage form is also described, together with packaging suitable for long term storage of the dosage form. | ||||||||||||||||||
| Designated States: |
AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW. African Regional Intellectual Property Org. (ARIPO) (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW) Eurasian Patent Organization (EAPO) (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM) European Patent Office (EPO) (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE) African Intellectual Property Organization (OAPI) (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG). | ||||||||||||||||||
| Publication Language: | English (EN) |
| Filing Language: | English (EN) |
